| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA12
|
ATP-binding cassette, sub-family A (ABC1), member 12
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI3
|
ABI family, member 3
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACIN1
|
apoptotic chromatin condensation inducer 1
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACO1
|
aconitase 1, soluble
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ACTR1A
|
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast)
|
|
ACVR1
|
activin A receptor, type I
|
|
ADA
|
adenosine deaminase
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAT2
|
adenosine deaminase, tRNA-specific 2
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADRBK2
|
adrenergic, beta, receptor kinase 2
|
|
AES
|
amino-terminal enhancer of split
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGRN
|
agrin
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AJUBA
|
ajuba LIM protein
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA13
|
annexin A13
|
|
ANXA2
|
annexin A2
|
|
AOX1
|
aldehyde oxidase 1
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APLNR
|
apelin receptor
|
|
APOE
|
apolipoprotein E
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARSB
|
arylsulfatase B
|
|
ASAP1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASCL2
|
achaete-scute family bHLH transcription factor 2
|
|
ASIP
|
agouti signaling protein
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ASPRV1
|
aspartic peptidase, retroviral-like 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATP1B2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATRAID
|
all-trans retinoic acid-induced differentiation factor
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AXIN1
|
axin 1
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
|
|
B3GNT8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCOR
|
BCL6 corepressor
|
|
BCR
|
breakpoint cluster region
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BLOC1S2
|
biogenesis of lysosomal organelles complex-1, subunit 2
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP3
|
bone morphogenetic protein 3
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP5
|
bone morphogenetic protein 5
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMPER
|
BMP binding endothelial regulator
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BSG
|
basigin (Ok blood group)
|
|
BTC
|
betacellulin
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C3ORF35
|
chromosome 3 open reading frame 35
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CACYBP
|
calcyclin binding protein
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALB2
|
calbindin 2
|
|
CALML3
|
calmodulin-like 3
|
|
CALR
|
calreticulin
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPZA1
|
capping protein (actin filament) muscle Z-line, alpha 1
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
|
CASR
|
calcium-sensing receptor
|
|
CASZ1
|
castor zinc finger 1
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBR3
|
carbonyl reductase 3
|
|
CBS
|
cystathionine-beta-synthase
|
|
CBX7
|
chromobox homolog 7
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNT1
|
cyclin T1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD24
|
CD24 molecule
|
|
CD247
|
CD247 molecule
|
|
CD27
|
CD27 molecule
|
|
CD276
|
CD276 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD80
|
CD80 molecule
|
|
CD82
|
CD82 molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC20
|
cell division cycle 20
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC6
|
cell division cycle 6
|
|
CDC7
|
cell division cycle 7
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHD1L
|
chromodomain helicase DNA binding protein 1-like
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHKA
|
choline kinase alpha
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLCN7
|
chloride channel, voltage-sensitive 7
|
|
CLDN1
|
claudin 1
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLDN6
|
claudin 6
|
|
CLDN7
|
claudin 7
|
|
CLU
|
clusterin
|
|
CMA1
|
chymase 1, mast cell
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COBLL1
|
cordon-bleu WH2 repeat protein-like 1
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL11A2
|
collagen, type XI, alpha 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
COX2
|
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CPT2
|
carnitine palmitoyltransferase 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTAM
|
cytotoxic and regulatory T cell molecule
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRX
|
cone-rod homeobox
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSPG4
|
chondroitin sulfate proteoglycan 4
|
|
CST3
|
cystatin C
|
|
CST6
|
cystatin E/M
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTGF
|
connective tissue growth factor
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CUX1
|
cut-like homeobox 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DACT1
|
dishevelled-binding antagonist of beta-catenin 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DAXX
|
death-domain associated protein
|
|
DCN
|
decorin
|
|
DCXR
|
dicarbonyl/L-xylulose reductase
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDX39A
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A
|
|
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEPDC1
|
DEP domain containing 1
|
|
DEPDC1B
|
DEP domain containing 1B
|
|
DES
|
desmin
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DNAJB6
|
DnaJ (Hsp40) homolog, subfamily B, member 6
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP3
|
dipeptidyl-peptidase 3
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP7
|
dipeptidyl-peptidase 7
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSG2
|
desmoglein 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP2
|
dual specificity phosphatase 2
|
|
DUSP26
|
dual specificity phosphatase 26 (putative)
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DUSP7
|
dual specificity phosphatase 7
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EAPP
|
E2F-associated phosphoprotein
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECM1
|
extracellular matrix protein 1
|
|
EDA2R
|
ectodysplasin A2 receptor
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EED
|
embryonic ectoderm development
|
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2
|
|
EFNB1
|
ephrin-B1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHF
|
ets homologous factor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF3H
|
eukaryotic translation initiation factor 3, subunit H
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EMP3
|
epithelial membrane protein 3
|
|
EN2
|
engrailed homeobox 2
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHA4
|
EPH receptor A4
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB3
|
EPH receptor B3
|
|
EPHB4
|
EPH receptor B4
|
|
EPHB6
|
EPH receptor B6
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
EREG
|
epiregulin
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV4
|
ets variant 4
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL2
|
coagulation factor II (thrombin) receptor-like 2
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FECH
|
ferrochelatase
|
|
FEM1B
|
fem-1 homolog b (C. elegans)
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FFAR2
|
free fatty acid receptor 2
|
|
FGF17
|
fibroblast growth factor 17
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FN3K
|
fructosamine 3 kinase
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN1
|
forkhead box N1
|
|
FOXN3
|
forkhead box N3
|
|
FOXO1
|
forkhead box O1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FOXQ1
|
forkhead box Q1
|
|
FPR1
|
formyl peptide receptor 1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FTL
|
ferritin, light polypeptide
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAS5
|
growth arrest-specific 5 (non-protein coding)
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GDF10
|
growth differentiation factor 10
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLO1
|
glyoxalase I
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNMT
|
glycine N-methyltransferase
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPR26
|
G protein-coupled receptor 26
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX2
|
glutathione peroxidase 2
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSR
|
glutathione reductase
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HAS3
|
hyaluronan synthase 3
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC11
|
histone deacetylase 11
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HELLS
|
helicase, lymphoid-specific
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLTF
|
helicase-like transcription factor
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HN1
|
hematological and neurological expressed 1
|
|
HNRNPF
|
heterogeneous nuclear ribonucleoprotein F
|
|
HNRNPH1
|
heterogeneous nuclear ribonucleoprotein H1 (H)
|
|
HOPX
|
HOP homeobox
|
|
HOTAIR
|
HOX transcript antisense RNA
|
|
HOXA6
|
homeobox A6
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HOXB5
|
homeobox B5
|
|
HOXB7
|
homeobox B7
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTRA3
|
HtrA serine peptidase 3
|
|
HYAL1
|
hyaluronoglucosaminidase 1
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2-AS
|
IGF2 antisense RNA
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL31
|
interleukin 31
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
ILK
|
integrin-linked kinase
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBE
|
inhibin, beta E
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAG2
|
jagged 2
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JAM3
|
junctional adhesion molecule 3
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KAZALD1
|
Kazal-type serine peptidase inhibitor domain 1
|
|
KCMF1
|
potassium channel modulatory factor 1
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM5A
|
lysine (K)-specific demethylase 5A
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIAA0101
|
KIAA0101
|
|
KIAA1524
|
KIAA1524
|
|
KIF23
|
kinesin family member 23
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KPNA7
|
karyopherin alpha 7 (importin alpha 8)
|
|
KPNB1
|
karyopherin (importin) beta 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT6B
|
keratin 6B, type II
|
|
KRT8
|
keratin 8, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
L1RE1
|
LINE1 retrotransposable element 1
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMB3
|
laminin, beta 3
|
|
LAP3
|
leucine aminopeptidase 3
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCMT2
|
leucine carboxyl methyltransferase 2
|
|
LCN2
|
lipocalin 2
|
|
LEFTY1
|
left-right determination factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
|
LHX9
|
LIM homeobox 9
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LIMS2
|
LIM and senescent cell antigen-like domains 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO3
|
LIM domain only 3 (rhombotin-like 2)
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPAR4
|
lysophosphatidic acid receptor 4
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRIG1
|
leucine-rich repeats and immunoglobulin-like domains 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LUM
|
lumican
|
|
LXN
|
latexin
|
|
LY9
|
lymphocyte antigen 9
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGEA9
|
melanoma antigen family A9
|
|
MAGED1
|
melanoma antigen family D1
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAT2B
|
methionine adenosyltransferase II, beta
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3AP
|
minichromosome maintenance complex component 3 associated protein
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED12
|
mediator complex subunit 12
|
|
MED19
|
mediator complex subunit 19
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEST
|
mesoderm specific transcript
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR106B
|
microRNA 106b
|
|
MIR10B
|
microRNA 10b
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR126
|
microRNA 126
|
|
MIR135A1
|
microRNA 135a-1
|
|
MIR137
|
microRNA 137
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR16-2
|
microRNA 16-2
|
|
MIR17
|
microRNA 17
|
|
MIR181A1
|
microRNA 181a-1
|
|
MIR182
|
microRNA 182
|
|
MIR183
|
microRNA 183
|
|
MIR18A
|
microRNA 18a
|
|
MIR195
|
microRNA 195
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR197
|
microRNA 197
|
|
MIR198
|
microRNA 198
|
|
MIR199B
|
microRNA 199b
|
|
MIR19A
|
microRNA 19a
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR204
|
microRNA 204
|
|
MIR205
|
microRNA 205
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR214
|
microRNA 214
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR224
|
microRNA 224
|
|
MIR23A
|
microRNA 23a
|
|
MIR27A
|
microRNA 27a
|
|
MIR30A
|
microRNA 30a
|
|
MIR30D
|
microRNA 30d
|
|
MIR30E
|
microRNA 30e
|
|
MIR31
|
microRNA 31
|
|
MIR328
|
microRNA 328
|
|
MIR335
|
microRNA 335
|
|
MIR34A
|
microRNA 34a
|
|
MIR34C
|
microRNA 34c
|
|
MIR375
|
microRNA 375
|
|
MIR449B
|
microRNA 449b
|
|
MIR483
|
microRNA 483
|
|
MIR497
|
microRNA 497
|
|
MIR503
|
microRNA 503
|
|
MIR506
|
microRNA 506
|
|
MIR625
|
microRNA 625
|
|
MIR632
|
microRNA 632
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR9-2
|
microRNA 9-2
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP28
|
matrix metallopeptidase 28
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MMS19
|
MMS19 nucleotide excision repair homolog (S. cerevisiae)
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MS4A12
|
membrane-spanning 4-domains, subfamily A, member 12
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSI1
|
musashi RNA-binding protein 1
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSLN
|
mesothelin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX2
|
msh homeobox 2
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MT3
|
metallothionein 3
|
|
MTA1
|
metastasis associated 1
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC15
|
mucin 15, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYO18B
|
myosin XVIIIB
|
|
MYO6
|
myosin VI
|
|
MYO7A
|
myosin VIIA
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAPSB
|
napsin B aspartic peptidase, pseudogene
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDRG3
|
NDRG family member 3
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NEK2
|
NIMA-related kinase 2
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIA
|
nuclear factor I/A
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NHLH2
|
nescient helix loop helix 2
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NMB
|
neuromedin B
|
|
NMBR
|
neuromedin B receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPTX2
|
neuronal pentraxin II
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTS
|
neurotensin
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUDC
|
nudC nuclear distribution protein
|
|
NUP98
|
nucleoporin 98kDa
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OCIAD1
|
OCIA domain containing 1
|
|
OCIAD2
|
OCIA domain containing 2
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLFM4
|
olfactomedin 4
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OSTM1
|
osteopetrosis associated transmembrane protein 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P4HB
|
prolyl 4-hydroxylase, beta polypeptide
|
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK7
|
p21 protein (Cdc42/Rac)-activated kinase 7
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX8
|
paired box 8
|
|
PBK
|
PDZ binding kinase
|
|
PBLD
|
phenazine biosynthesis-like protein domain containing
|
|
PC
|
pyruvate carboxylase
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCDH10
|
protocadherin 10
|
|
PCDH11Y
|
protocadherin 11 Y-linked
|
|
PCDH17
|
protocadherin 17
|
|
PCDH8
|
protocadherin 8
|
|
PCDHGA11
|
protocadherin gamma subfamily A, 11
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD5
|
programmed cell death 5
|
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDE9A
|
phosphodiesterase 9A
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDPN
|
podoplanin
|
|
PDZK1IP1
|
PDZK1 interacting protein 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER1
|
period circadian clock 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHF1
|
PHD finger protein 1
|
|
PHF20L1
|
PHD finger protein 20-like 1
|
|
PHLPP2
|
PH domain and leucine rich repeat protein phosphatase 2
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PI4K2B
|
phosphatidylinositol 4-kinase type 2 beta
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PIWIL1
|
piwi-like RNA-mediated gene silencing 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLS3
|
plastin 3
|
|
PLXNA1
|
plexin A1
|
|
PLXNB1
|
plexin B1
|
|
PLXND1
|
plexin D1
|
|
PMEL
|
premelanosome protein
|
|
PML
|
promyelocytic leukemia
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POT1
|
protection of telomeres 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma
|
|
PRAF2
|
PRA1 domain family, member 2
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PREP
|
prolyl endopeptidase
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCDBP
|
protein kinase C, delta binding protein
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD3
|
protein kinase D3
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROK2
|
prokineticin 2
|
|
PROM1
|
prominin 1
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMC6P1
|
proteasome 26S subunit, ATPase, 6 pseudogene 1
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTN
|
pleiotrophin
|
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1
|
|
PTP4A2
|
protein tyrosine phosphatase type IVA, member 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PUM1
|
pumilio RNA-binding family member 1
|
|
PVR
|
poliovirus receptor
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PXN
|
paxillin
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RASL10A
|
RAS-like, family 10, member A
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF10
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10
|
|
RASSF3
|
Ras association (RalGDS/AF-6) domain family member 3
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBMX
|
RNA binding motif protein, X-linked
|
|
RBP2
|
retinol binding protein 2, cellular
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RHBDD1
|
rhomboid domain containing 1
|
|
RHBDD3
|
rhomboid domain containing 3
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOC
|
ras homolog family member C
|
|
RHOD
|
ras homolog family member D
|
|
RLIM
|
ring finger protein, LIM domain interacting
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
RND3
|
Rho family GTPase 3
|
|
RNF4
|
ring finger protein 4
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPL19
|
ribosomal protein L19
|
|
RPS3
|
ribosomal protein S3
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RPSA
|
ribosomal protein SA
|
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RSU1
|
Ras suppressor protein 1
|
|
RUNDC3B
|
RUN domain containing 3B
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A11
|
S100 calcium binding protein A11
|
|
S100A13
|
S100 calcium binding protein A13
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
SAA1
|
serum amyloid A1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAPCD2
|
suppressor APC domain containing 2
|
|
SATB1
|
SATB homeobox 1
|
|
SATB2
|
SATB homeobox 2
|
|
SCG2
|
secretogranin II
|
|
SCML2
|
sex comb on midleg-like 2 (Drosophila)
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCUBE3
|
signal peptide, CUB domain, EGF-like 3
|
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
|
SDC1
|
syndecan 1
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SDK1
|
sidekick cell adhesion molecule 1
|
|
SEC11A
|
SEC11 homolog A (S. cerevisiae)
|
|
SELENBP1
|
selenium binding protein 1
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SETD2
|
SET domain containing 2
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFMBT1
|
Scm-like with four mbt domains 1
|
|
SFN
|
stratifin
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3GL3
|
SH3-domain GRB2-like 3
|
|
SH3GLB1
|
SH3-domain GRB2-like endophilin B1
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SHOX2
|
short stature homeobox 2
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SIRT1
|
sirtuin 1
|
|
SIX1
|
SIX homeobox 1
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1
|
|
SLC39A2
|
solute carrier family 39 (zinc transporter), member 2
|
|
SLC39A3
|
solute carrier family 39 (zinc transporter), member 3
|
|
SLC39A9
|
solute carrier family 39, member 9
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMTN
|
smoothelin
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPR
|
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRR2A
|
small proline-rich protein 2A
|
|
SPRR3
|
small proline-rich protein 3
|
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila)
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRPX
|
sushi-repeat containing protein, X-linked
|
|
SRY
|
sex determining region Y
|
|
SSTR4
|
somatostatin receptor 4
|
|
SSTR5
|
somatostatin receptor 5
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
ST3GAL6
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
ST7
|
suppression of tumorigenicity 7
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
STEAP3
|
STEAP family member 3, metalloreductase
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
STRAP
|
serine/threonine kinase receptor associated protein
|
|
SULF2
|
sulfatase 2
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TACR1
|
tachykinin receptor 1
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
TBC1D24
|
TBC1 domain family, member 24
|
|
TBX5
|
T-box 5
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCIRG1
|
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TERC
|
telomerase RNA component
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFF1
|
trefoil factor 1
|
|
TFF2
|
trefoil factor 2
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TKTL1
|
transketolase-like 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
TMPO
|
thymopoietin
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNXB
|
tenascin XB
|
|
TOMM40
|
translocase of outer mitochondrial membrane 40 homolog (yeast)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TOP3A
|
topoisomerase (DNA) III alpha
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPO
|
thyroid peroxidase
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRAPPC4
|
trafficking protein particle complex 4
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM29
|
tripartite motif containing 29
|
|
TRIM3
|
tripartite motif containing 3
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D1
|
TSC22 domain family, member 1
|
|
TSG101
|
tumor susceptibility 101
|
|
TSGA10
|
testis specific, 10
|
|
TSPAN33
|
tetraspanin 33
|
|
TSPO
|
translocator protein (18kDa)
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTC4
|
tetratricopeptide repeat domain 4
|
|
TUBA1B
|
tubulin, alpha 1b
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUBG1
|
tubulin, gamma 1
|
|
TUSC2
|
tumor suppressor candidate 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXLNA
|
taxilin alpha
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBAP1
|
ubiquitin associated protein 1
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBE2T
|
ubiquitin-conjugating enzyme E2T
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UHMK1
|
U2AF homology motif (UHM) kinase 1
|
|
UHRF2
|
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
UPK3A
|
uroplakin 3A
|
|
VASH1
|
vasohibin 1
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VCAN
|
versican
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VENTX
|
VENT homeobox
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWF
|
von Willebrand factor
|
|
WASF1
|
WAS protein family, member 1
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZFP36L1
|
ZFP36 ring finger protein-like 1
|
|
ZFX
|
zinc finger protein, X-linked
|
|
ZIC1
|
Zic family member 1
|
